Results 161 to 170 of about 39,632 (214)

Low-volume multiplex solid-phase PCR without DNA extraction for etiological diagnosis of infectious uveitis. [PDF]

Indian J Ophthalmol
Ferracioli-Oda E, Tanaka T, Gouvea MSG, Pinho JRR, Coelho V, Bispo PJM, Hirata CE, Yamamoto JH.   +7 more
europepmc   +1 more source

Global epidemiology of HTLV: Under-reported and under-studied regions. [PDF]

North Clin Istanb
Mardnaybin H, Demirci M, Uysal HK.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Human T lymphotropic virus‐1 infection

Australasian Journal of Dermatology, 1996
SUMMARYHuman T lymphotropic virus‐1 (HTLV‐1) is a retrovirus which infects T lymphocytes (CD4+) to cause adult T cell leukaemia/lymphoma (ATL), tropical spastic paraparesis and several other HTLV‐1 associated disorders. ATL has been reported worldwide but areas of high incidence include Japan (particularly the south‐west), Central and South America ...
T, Kanzaki, M, Setoyama, Y, Katahira
openaire   +2 more sources

Human T-lymphotropic virus type 1 infection

Best Practice & Research Clinical Haematology, 2000
Human T-cell lymphotropic virus type-1 (HTLV-1) is aetiologically associated with adult T-cell leukaemia/lymphoma (ATL). HTLV-1 infection can also lead to various non-malignant diseases, for example, HTLV-1 associated myelopathy/tropical spastic paraparesis and HTLV-1 uveitis. HTLV-1 is endemic in southern Japan and the Caribbean.
K, Tsukasaki, P, Koeffler, M, Tomonaga
openaire   +2 more sources

Human T-lymphotropic virus 1 neurologic disease

Current Treatment Options in Neurology, 2008
Human T-lymphotrophic virus 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a disabling myelopathy, but clinical trials of specific drugs to treat it are lacking. There are many reasons for the absence of specific therapeutic studies, including difficulty in enrolling patients, inadequate measurement tools to evaluate ...
Abelardo, Araújo, Marco Antonio, Lima, Marcus Tulius T, Silva   +2 more
openaire   +2 more sources

Infection of defective human T-lymphotropic virus type 1

Human Cell, 2017
In a previous study, we reported that an identical defective provirus had integrated into multiple sites of the genome of a representative human T-lymphotropic virus type 1 (HTLV-1) cell line, MT-2. A possible explanation for this may be the repeated infection of this defective provirus to a cell.
Yuuki, Hashikura, Kazumi, Umeki, Kunihiko, Umekita, Hajime, Nomura, Akiteru, Yamada, Ikuo, Yamamoto, Hiroo, Hasegawa, Katsunori, Yanagihara, Akihiko, Okayama   +8 more
openaire   +2 more sources

Human T‐lymphotropic Virus 1 (HTLV‐1) infection – dermatological implications

International Journal of Dermatology, 2011
AbstractHuman T‐lymphotropic virus type 1 (HTLV‐1) is a type C retrovirus primarily endemic to Japan, Central and South America, the Middle East, regions of Africa, and the Caribbean. Currently, an estimated 10–20 million people worldwide are infected with this virus.
Masahiro, Amano, Mitsuru, Setoyama, Annika, Grant, Francisco A, Kerdel   +3 more
openaire   +2 more sources

[Human T-lymphotropic virus type 1 uveitis in children].

Nippon Ganka Gakkai zasshi, 1997
We report here five pediatric patients with human T-lymphotropic virus type 1 (HTLV-I) uveitis. The patients were one boy and four girls aged between 3 and 14 years. The transmission route was considered to be breast feeding from their mothers. All patients had unilateral uveitis and the ocular symptoms were similar to those in HTLV-I uveitis in adults.
K, Kihara, M, Tsuruda, A, Ono, E, Ikeda, N, Hikita, N, Miyata, M, Mochizuki   +6 more
openaire   +3 more sources